Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 16, 2020 - Issue 11
Submit an article Journal homepage
894
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II)

Peter E. Silasa Wee Care Pediatrics, Syracuse, UT, USAView further author information
,
Edward N. Zissmanb Children’s Research at Altamonte Pediatric Associates, Lake Mary, FL, USAView further author information
,
Julie Gardnerc Merck & Co., Inc., Kenilworth, NJ, USACorrespondence[email protected]
View further author information
,
Shanjun Helianc Merck & Co., Inc., Kenilworth, NJ, USAORCID Iconhttps://orcid.org/0000-0002-7008-580XView further author information
ORCID Icon,
Andrew W. Leec Merck & Co., Inc., Kenilworth, NJ, USAView further author information
&
Heather L. Plattc Merck & Co., Inc., Kenilworth, NJ, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0910-6077View further author information
ORCID Icon
Pages 2634-2640 | Received 18 Dec 2019, Accepted 10 Mar 2020, Published online: 19 May 2020

References

  • Straus SE, Ostrove JM, Inchauspé G, Felser JM, Freifeld A, Croen KD, Sawyer MH. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med. 1988;108(2):221–37. doi:10.7326/0003-4819-108-2-221.
  • Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis. 1995;172(3):706–12. doi:10.1093/infdis/172.3.706.
  • Guess HA, Broughton DD, Melton LJ, Kurland LT. Population-based studies of varicella complications. Pediatrics. 1986;78:723–27.
  • Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am. 1996;10(3):571-&. doi:10.1016/S0891-5520(05)70313-5.
  • Galil K, Brown C, LIN F, Seward J. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J. 2002;21(10):931–35. doi:10.1097/00006454-200210000-00009.
  • Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality: trends before vaccine licensure in the United States, 1970–1994. J Infect Dis. 2000;182(2):383–90. doi:10.1086/315714.
  • Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, Gargiullo P, Perella D, Civen R, Seward JF. Changing varicella epidemiology in active surveillance sites–United States, 1995–2005. J Infect Dis. 2008;197(Suppl 2):S71–5. doi:10.1086/522156.
  • Luman ET, Ching PL, Jumaan AO, Seward JF. Uptake of varicella vaccination among young children in the United States: a success story in eliminating racial and ethnic disparities. Pediatrics. 2006;117(4):999–1008. doi:10.1542/peds.2005-1201.
  • Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA. 2005;294(7):797–802. doi:10.1001/jama.294.7.797.
  • Centers For Disease Control. Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP). MMWR. 2007;56(RR–4):1-CE-4.
  • Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011;128(2):214–20. doi:10.1542/peds.2010-3385.
  • Baxter R, Ray P, Tran TN, Black S, Shinefield HR, Coplan PM, Lewis E, Fireman B, Saddier P. Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study. Pediatrics. 2013;131(5):e1389–96. doi:10.1542/peds.2012-3303.
  • Centers For Disease Control And Prevention. Recommended immunization schedules for persons aged 0–18 years-United States, 2007. MMWR. 2007;55(51):Q1–Q4.
  • Senders SD, Bundick ND, Li J, Zecca C, Helmond FA. Evaluation of immunogenicity and safety of VARIVAX New Seed Process (NSP) in children. Hum Vaccin Immunother. 2018;14(2):442–49. doi:10.1080/21645515.2017.1388479.
  • Ngai AL, Staehle BO, Kuter BJ, Cyanovich NM, Cho I, Matthews H, Keller P, Arvin AM, Watson B, White CJ. Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children. Pediatr Infect Dis J. 1996;15(1):49–54. doi:10.1097/00006454-199601000-00011.
  • Keller PM, Lonergan K, Neff BJ, Morton DA, Ellis RW. Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies. J Virol Methods. 1986;14(2):177–88. doi:10.1016/0166-0934(86)90048-0.
  • Wasmuth EH, Miller WJ. Sensitive enzyme-linked-immunosorbent-assay for antibody to varicella-zoster virus using purified vzv glycoprotein antigen. J Med Virol. 1990;32(3):189–93. doi:10.1002/()1096-9071.
  • Provost PJ, Krah D, Kuter B, Morton D, Schofield T, Wasmuth E, White C, Miller W, Ellis R. Antibody-assays suitable for assessing immune-responses to live varicella vaccine. Vaccine. 1991;9(2):111–16. doi:10.1016/0264-410X(91)90266-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.